Hit and Run: How Viruses Could Spur Alzheimer’s—and How Vaccines Can...
By Andrew Bubak, Diego Restrepo, and Maria Nagel, College of Colorado Anschutz Medical Campus | February thirteenth, 2023 Researchers on the...
COVID Can Cause Long-term Cognitive Symptoms. But Why?
By Samudyata and Carl Sellgren, Karolinska Institutet | February tenth, 2023 For a portion of people that get COVID, signs...
Is Your Brain ‘Old for Its Age’? How AI Measures Cognitive...
By Katy Koop | February ninth, 2023 USC quantitative neuroscientist Dr. Andrei Irimia joins Being Affected person Dwell Talks to debate...
How Do You Treat Alzheimer’s Aggression?
FAQ: “What are the remedies for aggression in Alzheimer’s illness?” Managing aggression in Alzheimer’s, safely Alzheimer’s illness is a progressive neurodegenerative dysfunction that impacts...
The...
Being Patient | The Latest Developments on Alzheimer’s Disease
Andrea Couture Andrea Couture is the writer of “Embracing What Stays,” a memoir about balancing motherhood and...
Being Patient | The Latest Developments on Alzheimer’s Disease
Andrea Couture
Andrea Couture is the writer of “Embracing What Stays,” a memoir about balancing motherhood and daughterhood following her father’s Alzheimer’s analysis. When my...
Being Patient | The Latest Developments on Alzheimer’s Disease
Andrea Couture Andrea Couture is the writer of “Embracing What Stays,” a memoir about balancing motherhood and...
Being Patient | The Latest Developments on Alzheimer’s Disease
Andrea Couture
Andrea Couture is the creator of “Embracing What Stays,” a memoir about balancing motherhood and daughterhood following her father’s Alzheimer’s prognosis. When my...
Being Patient | The Latest Developments on Alzheimer’s Disease
Andrea Couture
Andrea Couture is the creator of “Embracing What Stays,” a memoir about balancing motherhood and daughterhood following her father’s Alzheimer’s analysis. When my...
Leqembi Trials Aren’t Over; Joining Could Save $26,500 Per Year
Involved in Leqembi? Scientific trials are nonetheless ongoing, and individuals have a 50/50 likelihood of receiving the $26,500-per-year drug free of charge. ...
- Advertisement -